• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物洗脱支架植入术后一年的冠状动脉血管运动:依维莫司洗脱冠状动脉支架与紫杉醇洗脱冠状动脉支架的比较

Coronary vasomotion one year after drug-eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents.

作者信息

Hamilos Michalis, Ribichini Flavio, Ostojic Miodrag C, Ferrero Valeria, Orlic Dejan, Vassanelli Corrado, Karanovic Nevena, Sarno Giovanna, Cuisset Thomas, Vardas Panos E, Wijns William

机构信息

Cardiology Department, University Hospital of Heraklion, Heraklion, Greece.

出版信息

J Cardiovasc Transl Res. 2014 Jun;7(4):406-12. doi: 10.1007/s12265-014-9568-2. Epub 2014 May 3.

DOI:10.1007/s12265-014-9568-2
PMID:24794876
Abstract

First-generation drug-eluting stents (DES) have been associated with impaired localized coronary vasomotion and delayed endothelialization. We aimed to compare coronary vasomotion after implantation of a newer-generation everolimus-eluting stent (EES), with a first-generation paclitaxel-eluting stent (PES). Coronary vasomotion was studied in 19 patients with EES and 13 with PES. Vasomotor response was measured proximally and distally to the stent and in a remote vessel (reference segment). Quantitative coronary angiography was performed offline. Endothelium independent vasomotion did not differ significantly between the two groups. EES showed significant vasodilatation while PES showed vasoconstriction at both proximal (+4.5 ± 3.6 vs -4.2 ± 6.9, p < 0.001) and distal (+4.6 ± 7.9 vs -4.8 ± 9.3, p = 0.003) segments. The reference segment did not show any significant difference in vasodilatation between the two groups (+9.8 ± 6.4 vs +7.2 ± 5.2, p = 0.17). Endothelium-dependent vasomotion at adjacent stent segments is relatively preserved after EES implantation while vasoconstriction was observed after PES implantation.

摘要

第一代药物洗脱支架(DES)与局部冠状动脉血管运动受损和内皮化延迟有关。我们旨在比较新一代依维莫司洗脱支架(EES)与第一代紫杉醇洗脱支架(PES)植入后的冠状动脉血管运动情况。对19例植入EES的患者和13例植入PES的患者进行了冠状动脉血管运动研究。在支架近端和远端以及一个远离的血管(参照节段)测量血管舒缩反应。离线进行定量冠状动脉造影。两组之间内皮依赖性血管运动无显著差异。EES在近端(+4.5±3.6对-4.2±6.9,p<0.001)和远端(+4.6±7.9对-4.8±9.3,p=0.003)节段均显示出显著的血管扩张,而PES则显示血管收缩。两组在参照节段的血管扩张方面无任何显著差异(+9.8±6.4对+7.2±5.2,p=0.17)。EES植入后相邻支架节段的内皮依赖性血管运动相对得以保留,而PES植入后则观察到血管收缩。

相似文献

1
Coronary vasomotion one year after drug-eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents.药物洗脱支架植入术后一年的冠状动脉血管运动:依维莫司洗脱冠状动脉支架与紫杉醇洗脱冠状动脉支架的比较
J Cardiovasc Transl Res. 2014 Jun;7(4):406-12. doi: 10.1007/s12265-014-9568-2. Epub 2014 May 3.
2
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).XIENCE V 依维莫司洗脱冠状动脉支架系统治疗多支冠状动脉疾病患者的临床和血管造影研究:EXECUTIVE 试验(EXecutive RCT:评估 XIENCE V 在多支血管疾病中的应用)。
JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18.
3
Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study.生物可吸收聚合物涂层西罗莫司洗脱支架植入术可保留冠状动脉血管运动功能:一项DESSOLVE II试验子研究。
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1141-50. doi: 10.1002/ccd.25610. Epub 2015 Sep 22.
4
Preserved endothelial vasomotor function after everolimus-eluting stent implantation.经依维莫司洗脱支架植入术后内皮血管舒缩功能得到保留。
EuroIntervention. 2015 Oct;11(6):643-9. doi: 10.4244/EIJY14M07_09.
5
Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.紫杉醇和依维莫司洗脱支架植入后 3 个月在链脲佐菌素诱导的糖尿病猪冠状动脉中的比较血管反应。
Cardiovasc Diabetol. 2012 Jun 21;11:75. doi: 10.1186/1475-2840-11-75.
6
Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.药物洗脱支架对局部内皮依赖性冠状动脉血管运动的不同影响。
J Am Coll Cardiol. 2008 Jun 3;51(22):2123-9. doi: 10.1016/j.jacc.2007.12.059.
7
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).在冠状动脉疾病中,依维莫司洗脱支架与紫杉醇洗脱支架的荟萃分析:SPIRIT 临床试验计划的最终 3 年结果(在治疗新发病变的患者中,使用依维莫司洗脱冠状动脉支架系统治疗的西里斯 V 依维莫司洗脱冠状动脉支架系统的临床评估)。
JACC Cardiovasc Interv. 2013 Sep;6(9):914-22. doi: 10.1016/j.jcin.2013.05.005.
8
5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).SPIRIT III 试验的 5 年随机对照研究结果:依维莫司洗脱 XIENCE V 支架与紫杉醇洗脱 Taxus 支架的比较——治疗初发的 native 冠状动脉病变患者的 XIENCE V 依维莫司洗脱冠状动脉支架系统的临床评估。
JACC Cardiovasc Interv. 2013 Dec;6(12):1263-6. doi: 10.1016/j.jcin.2013.07.009. Epub 2013 Nov 13.
9
Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.药物洗脱支架植入后6个月的形态学、功能学及生物学血管愈合反应:三种药物洗脱支架的随机对照研究
Catheter Cardiovasc Interv. 2016 Sep;88(3):350-7. doi: 10.1002/ccd.26273. Epub 2015 Nov 3.
10
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial.比较依维莫司洗脱支架与紫杉醇洗脱支架的血管反应:来自 SPIRIT III 试验的血管内超声结果。
EuroIntervention. 2012 Oct;8(6):724-31. doi: 10.4244/EIJV8I6A112.

引用本文的文献

1
Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?导尿管对动脉功能和健康的影响:冠心病介入治疗后患者何时开始运动?
Sports Med. 2019 Mar;49(3):397-416. doi: 10.1007/s40279-019-01055-3.
2
Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial.依维莫司洗脱支架和依维莫司洗脱生物血管支架中光学相干断层扫描与血管运动的多分析:MOVES试验
Open Heart. 2018 Jan 3;5(1):e000624. doi: 10.1136/openhrt-2017-000624. eCollection 2018.

本文引用的文献

1
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。
Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.
2
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.依维莫司洗脱支架与紫杉醇洗脱支架治疗冠状动脉疾病的比较。
N Engl J Med. 2010 May 6;362(18):1663-74. doi: 10.1056/NEJMoa0910496.
3
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.
第二代依维莫司洗脱和紫杉醇洗脱支架在真实世界实践中的比较(COMPARE):一项随机试验。
Lancet. 2010 Jan 16;375(9710):201-9. doi: 10.1016/S0140-6736(09)62127-9. Epub 2010 Jan 7.
4
Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.药物洗脱支架对内皮依赖性冠状动脉血管舒缩的干扰:与器械相关的反应证据。
Circ Cardiovasc Interv. 2008 Dec;1(3):193-200. doi: 10.1161/CIRCINTERVENTIONS.108.797928.
5
The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.真实世界患者中的依维莫司洗脱支架:X-SEARCH(鹿特丹心脏医院评估的Xience V支架)注册研究的6个月随访
J Am Coll Cardiol. 2009 Jul 14;54(3):269-76. doi: 10.1016/j.jacc.2009.05.016.
6
Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.基于聚合物和非聚合物的西罗莫司洗脱支架的不同愈合反应
JACC Cardiovasc Interv. 2008 Oct;1(5):535-44. doi: 10.1016/j.jcin.2008.08.004.
7
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.依维莫司洗脱支架与紫杉醇洗脱支架的随机对照比较:来自Xience V依维莫司洗脱冠状动脉支架系统治疗初发原发性冠状动脉病变患者的临床评估(SPIRIT)III试验的两年临床随访
Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26.
8
Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the Xience V Everolimus-Eluting Coronary Stent.2007年美国食品药品监督管理局循环系统器械专家小组关于Xience V依维莫司洗脱冠状动脉支架会议概述。
Am J Cardiol. 2008 Dec 15;102(12):1624-30. doi: 10.1016/j.amjcard.2008.08.013. Epub 2008 Sep 24.
9
Systemic exposure of everolimus after stent implantation: a pharmacokinetic study.支架植入后依维莫司的全身暴露量:一项药代动力学研究。
Am Heart J. 2008 Oct;156(4):751.e1-7. doi: 10.1016/j.ahj.2008.07.005.
10
Endothelial cell recovery between comparator polymer-based drug-eluting stents.对比聚合物基药物洗脱支架之间的内皮细胞恢复情况。
J Am Coll Cardiol. 2008 Jul 29;52(5):333-42. doi: 10.1016/j.jacc.2008.04.030.